Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy

Table 2

HP-eradication: multivariate analysis.

Independent variables	𝑃 value	Odds ratio	95% Confidence interval
L. reuteri supplementation	0.026	3.055	1.146–8.150
Age	0.434	1.471	0.559–3.869
Sex	0.195	0.497	0.172–1.430